Plasma selenium concentration and prostate cancer risk : results from the European Prospective Investigation into Cancer and Nutrition ( EPIC ) 1 – 3

@inproceedings{Allen2008PlasmaSC,
  title={Plasma selenium concentration and prostate cancer risk : results from the European Prospective Investigation into Cancer and Nutrition ( EPIC ) 1 – 3},
  author={Naomi E. Allen and Paul N. Appleby and Andrew Wilfred Roddam and Anne Tj\onneland and Nina F\ons Johnsen and Kim Overvad and H. B{\"o}ing and Steffen Weikert and Rudolf Kaaks and Jakob P Linseisen and Antonia Trichopoulou and Gesthimani Misirli and Dimitirios Trichopoulos and Carlotta Sacerdote and Sara Grioni and Domenico Palli and Rosario Tumino and Hendrik Bas Bueno-de-Mesquita and Lambertus A Kiemeney and Aurelio Barricarte and N Guerrini de Larra{\~n}aga and M P{\'e}rez S{\'a}nchez and Antonio Agudo and Maria-Jose Tormo and Laudina Rodr{\'i}guez and P{\"a}r Stattin and G{\"o}ran Hallmans and Sheila Anne Bingham and Kay-Tee Khaw and Nadia Slimani and Sabina Rinaldi and Paolo Boffetta and Elio Riboli and Timothy J Key},
  year={2008}
}
Background: Some evidence indicates that a low selenium intake may be associated with an increased risk of prostate cancer. Objective: The aim of this study was to investigate the association of plasma selenium concentration with subsequent prostate cancer risk and to examine this association by stage and grade of disease and other factors. Design: A nested… CONTINUE READING